With 1000 subjects, there is good power at the minimum clinical effect, ∆ 1 .
With only 500 subjects, good power is achieved at the more optimistic ∆ 2 .
If θ = ∆ 2 , a sample size of 1000 is unnecessarily high. All designs, including adaptive procedures, have overall power curves.
Designs with similar power curves can be compared in terms of their average sample size functions, E θ (N ).
Even if there is uncertainty about the likely treatment effect, investigators should be able to specify the values of θ under which early stopping is most desirable. Adaptive designs can be as good as GSTs However, many published adaptive designs require higher expected sample sizes to achieve the same power as good GSTs.
Re-visiting the Group Sequential vs Adaptive question
The paper by Mehta & Pocock (Statistics in Medicine, 2011) "Adaptive increase in sample size when interim results are promising:
A practical guide with examples" has re-opened this question.
Conclusions of Mehta & Pocock (MP) are counter to the findings we have reported.
An important feature:
In MP's first example, response is measured some time after treatment.
Thus, at an interim analysis, many patients have been treated but are yet to produce a response.
Delayed responses are common -and not easily dealt with by standard GSTs.
Mehta & Pocock's Example
The initial plan is for a total of n 2 = 442 patients, 221 on each treatment.
In testing H 0 : θ ≤ 0 vs θ > 0, the final analysis will reject H 0 if Z 2
This design and analysis gives type I error rate 0.025 and power 0.8 at θ = 2.
Higher power, e.g., power 0.8 at θ = 1.6, would be desirable.
But, the sponsors will only increase sample size if interim results are "promising".
An interim analysis is planned after observing n 1 = 208 responses.
Increasing the sample size
At the interim analysis with n 1 = 208 observed responses, the estimated treatment effect is
and
At the time of this analysis, a further 208 subjects will have been treated for less than 26 weeks. Their responses will be observed in due course.
As recruitment continues, we use the value of Z 1 in choosing a new total sample size between the original figure of 442 and a maximum of 884.
In deciding whether to increase the sample size, MP consider conditional power of the original test (with n 2 = 442 observations), given the observed value of Z 1 .

Definition
The conditional power CP θ (z 1 ) is the probability the final test, with n 2 = 442 observations, rejects H 0 , given Z 1 = z 1 and effect size θ,
MP's adaptive design is based on conditional power under θ =θ 1 .
They divide the range of z 1 into three regions:
Continue to n 2 = 442,
Continue to n 2 = 442.
When increasing sample size in the promising zone, the final test of H 0 must protect the type I error rate at level α. Suppose at interim analysis 1, the final sample size is increased to n * 2 > n 2 and a final test is carried out without adjustment for this adaptation.
Thus, H 0 is rejected if
Chen, DeMets & Lan (CDL) show that if n 2 is only increased when
then the type I error probability will not increase. 
The MP design
In their "promising zone", MP increase n 2 to achieve conditional power 0.8 under θ = θ 1 , truncating this value to 884 if it is larger than that. Comparison with the distribution of θ 1 under θ = 1.6 shows that increases in n 2 occur in a region of quite small probability.
The distribution of θ 1 under other values of θ is shifted but has the same variance.
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Properties of the MP design
The increase in n 2 in the "promising zone" has increased the power curve a little. Given the limited range of values of θ 1 for which n 2 is increased, only a small improvement in power can be expected.
Although it was stated that power 0.8 at θ = 1.6 would be desirable, power at this effect size has only risen from 0.61 to 0.66.
The cost of higher power is an increase in expected sample size. Aiming for higher conditional power under θ = θ 1 or raising the sample size beyond 884 gives small increases in power at the cost of large increases in E(N ).
Alternatives to the MP design
Suppose we are satisfied with the overall power function attained by MP's design.
The same power curve can be achieved by other designs.
A fixed sample design
Emerson, Levin & Emerson (Statistics in Medicine, 2011) note that the same power is achieved by a fixed sample size study with 490 subjects.
This looks like an attractive option since, for effect sizes θ between 0.8 and 2.0, the expected sample size of the MP design is greater than 490.
There is more to the sample size distribution than E θ (N )
High variance in N is usually regarded as undesirable, so the wide variation in N for the MP design is a negative feature.
Perhaps variation in N is viewed more positively when investors in a small bio-tech company are thinking of adding resource to a study when it is most helpful?
A group sequential test
Despite the delayed response, we can still consider a group sequential design.
Suppose an interim analysis takes place after 208 observed responses.
If the trial stops at this analysis, the sample size is taken as 416, counting all subjects treated thus far, even though only 208 have provided a response.
We consider an error spending design in the ρ-family (JT 2000, Ch. Since 514 = 490 × 1.05, it has an "inflation factor" of R = 1.05. 
Deriving efficient sample size rules in the MP framework
We stay with MP's example and retain the basic elements of their design.
The interim analysis takes place after 208 observed responses.
A final sample size n * 2 is chosen based on θ 1 (or equivalently Z 1 ). 
Efficient sample size rules in the MP framework
We shall assess the conditional power that an increase in sample size achieves.
Suppose Z 1 = z 1 and we are considering a final sample size n * 2 with
and conditional power under θ =θ
Setting γ as a "rate of exchange" between sample size and power, we shall:
Choose n * 2 to optimise a combined objective
We shall do this withθ = 1.6, a value where we wish to "buy" additional power.
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An overall optimality property
The rule that maximises CPθ(z 1 , n * 2 (z 1 )) − γn * 2 (z 1 ) for every z 1 also maximises, unconditionally,
This can be seen by writing P θ=θ (Reject
where fθ(z 1 ) denotes the density of Z 1 under θ =θ, and noting that we have minimised the integrand for each z 1 .
We shall set γ = 0.14/(4 σ 2 ) to achieve the same power curve as the MP design.
So, the resulting procedure will have minimum possible E θ=1.6 (N ) among all designs following the CDL+Gao framework that achieve power 0.658 at θ = 1.6. The conditional power curve is steeper and the optimum occurs at a higher n * 2 .
The objective CPθ(z 1 , n * 2 ) − γ(n * 2 − 442) is maximised at n * 2 = 707.
In this case, MP's design takes the maximum permitted value of n * 2 = 884. This rule gives power 0.658 at θ = 1.6, the same as the MP design.
Decisions about the final sample size are based on a consistent comparison of the value of higher power and the cost of additional observations.
As θ 1 decreases, sample size increases less steeply than for the MP design. With the type I error rate at θ = 0 fixed at 0.025, matching the MP design's power at one value of θ implies matching the whole power curve.
Our optimised design has the same power curve as the MP design and lower
The reductions in E θ (N ) are modest -but given the optimality property of the sampling rule in the Mehta & Pocock framework, this is as good as it gets.
Further efficiency gains
Our new, optimised procedure still has higher E θ (N ) than the two-stage GST that ignores (but is charged for) pipeline data. 
Using the Conditional Probability of Rejection principle
Reference: Proschan & Hunsberger, (Biometrics, 1995) On observing θ 1 , choose a new final sample size n * 2 .
Then, set the critical value for Z 2 (n * 2 ) at the final analysis to maintain the Conditional Probability of Rejection (CPR) under θ = 0 in the original design.
The overall type I error rate is the integral of the conditional type I error rate, and this remains the same.
This type of adaptation can also be regarded as a "weighted inverse normal combination test" Bauer & Köhne (1994) .
We can follow our previous strategy in this new framework and set n * 2 to maximise CPθ(z 1 , n * 2 ) − γ(n * 2 − 442). Again, we shall useθ = 1.6.
The resulting design has the minimum value of Eθ(N ) among all designs in this larger class that achieve the same power under θ =θ. The CPR principle allows sample size increases for θ 1 below the CDL+Gao region.
This leads to a useful reduction in E θ (N ) at θ = 1.6.
Further extensions
1. We can allow recruitment to be terminated at the interim analysis, so the minimum final sample size is n 2 = 416, rather than 442.
2. We can use a general conditional type I error function (Proschan & Hunsberger, 1995) or, equivalently, a general Bauer & Köhne (1994) combination rule.
3. We can minimise other sample size criteria, such as a weighted sum or integral
The resulting designs deal neatly with the "pipeline" subjects arising when there is a delayed response.
They will give the best possible sampling and decision rules with n 1 = 208 and n 2 in the range 416 to 884.
(We could also aim for higher power, now we have a good way to achieve this.)
A general sampling rule with early termination of recruitment
We have followed (1) and (2) above in minimising E θ=1.6 (N ).
Sample size rule E θ (N ) curves Reductions in E θ (N ) are mostly due to (1), which allows n 2 to be limited to 416. Their "Delayed Response GSTs" allow any number of interim analyses and can be optimised for specified criteria.
Applying this approach in the case of just 2 analyses:
Either recruitment stops at analysis 1 and the final analysis occurs when all pipeline subjects have been observed, Or, an additional group of subjects is recruited and the final analysis has pipeline subjects plus these new subjects.
Thus, we have a special case of the designs we have been developing where only two values of n 2 are possible. The sampling rule approximates that of the general adaptive method, but with a step function rather than a continuous sample size function.
Plot of E θ (N ) for the optimal DR GST
The optimised DR GST has an almost identical E θ (N ) curve to the general rule using the continuum of possible sample sizes. is minimal benefit from fine-tuning the total sample size in response to interim data.
